1526 - Somatic tumour gene testing for the diagnosis of diffuse large B cell lymphoma, multiple myeloma and non-Hodgkin lymphoma subtypes

Page last updated: 03 April 2018

Application Detail

Status

Open

Description of Medical Service

The characterisation of: rearrangements in BCL2, BC16, MYC genes for detection of cases of 'double-hit' diffuse large B cell lymphoma, which require more intensive chemotherapy in view of the more aggressive nature of the lymphoma; copy number changes or mutations for the diagnosis and classification of neoplasms or the detection of minimal residual disease of patients with plasma cell myeloma; and histological diagnosis and classification for rare subtypes of non-hodgkin lymphoma.

Description of Medical Condition

Diffuse large B cell lymphoma; copy number abberations and / or mutations fo the diagnosis and classification of plasma cell myeloma; and rare sub-types of non-hodgkin lymphoma that respond poorly to conventional chemotherapy.

Reason for Application

New MBS item

Medical Service Type

Investigative

Previous Application Number

Not Applicable

Associated Documentation

Application Form

Application Form (Word 202 KB)
Application Form (PDF 1032 KB)

Consultation Survey

Consultation Survey (Word 508 KB)
Consultation Survey (PDF 306 KB)

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

12-13 April 2018

ESC

-

MSAC

-